Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro

Journal of Virology

Volumn 83, Issue 2, 2009, Pages 836-846

  Helbig, Karla J ^a,b   Ruszkiewicz, Andrew ^a   Lanford, Robert E ^c   Berzsenyi, Mark D ^d   Harley, Hugh A ^e   McColl, Shaun R ^b   Beard, Michael R ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d ALFRED HOSPITAL   (Australia)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; DOUBLE STRANDED RNA; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 3; LIGAND; LUCIFERASE; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ARTICLE; CHIMPANZEE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INNATE IMMUNITY; LIVER; LIVER DISEASE; MALE; MICROARRAY ANALYSIS; MODULATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REPORTER GENE; T LYMPHOCYTE; UPREGULATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINE CXCL11; CHEMOKINE CXCL9; GENE EXPRESSION PROFILING; GENES, REPORTER; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-GAMMA; LIVER; LUCIFERASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAN TROGLODYTES; TUMOR NECROSIS FACTOR-ALPHA;

HEPATITIS C VIRUS; PAN;

EID: 58149526773     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01388-08     Document Type: Article

References (48)

1. Abel, S., C. Hundhausen, R. Mentlein, A. Schulte, T. A. Berkhout, N. Broadway, D. Hartmann, R. Sedlacek, S. Dietrich, B. Muetze, B. Schuster, K. J. Kallen, P. Saftig, S. Rose-John, and A. Ludwig. 2004. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 172:6362-6372.
2. Apolinario, A., P. L. Majano, E. Alvarez-Perez, A. Saez, C. Lozano, J. Vargas, and C. Garcia-Monzon. 2002. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am. J. Gastroenterol. 97:2861-2870.
3. Asselah, T., I. Bieche, I. Laurendeau, V. Paradis, D. Vidaud, C. Degott, M. Martinot, P. Bedossa, D. Valla, M. Vidaud, and P. Marcellin. 2005. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 129:2064-2075.
4. Barnes, B., B. Lubyova, and P. M. Pitha. 2002. On the role of IRF in host defense. J. Interferon Cytokine Res. 22:59-71.
5. Bigger, C. B., B. Guerra, K. M. Brasky, G. Hubbard, M. R. Beard, B. A. Luxon, S. M. Lemon, and R. E. Lanford. 2004. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J. Virol. 78:13779-13792.
6. Brunt, E. M. 2000. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 31:241-246.
7. Di Bisceglie, A. M., Z. D. Goodman, K. G. Ishak, J. H. Hoofnagle, J. J. Melpolder, and H. J. Alter. 1991. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 14:969-974.
8. Di Bisceglie, A. M., L. H. Simpson, M. T. Lotze, and J. H. Hoofnagle. 1994. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J. Clin. Gastroenterol. 19:222-226.
9. Foy, E., K. Li, C. Wang, R. Sumpter, Jr., M. Ikeda, S. M. Lemon, and M. Gale, Jr. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145-1148.
10. Harvey, C. E., J. J. Post, P. Palladinetti, A. J. Freeman, R. A. Ffrench, R. K. Kumar, G. Marinos, and A. R. Lloyd. 2003. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J. Leukoc. Biol. 74:360-369.
11. He, X. S., B. Rehermann, F. X. Lopez-Labrador, J. Boisvert, R. Cheung, J. Mumm, H. Wedemeyer, M. Berenguer, T. L. Wright, M. M. Davis, and H. B. Greenberg. 1999. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc. Natl. Acad. Sci. USA 96:5692-5697.
12. Helbig, K. J., D. T. Lau, L. Semendric, H. A. Harley, and M. R. Beard. 2005. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42:702-710.
13. Helbig, K. J., A. Ruszkiewicz, L. Semendric, H. A. Harley, S. R. McColl, and M. R. Beard. 2004. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology 39:1220-1229.
14. Heydtmann, M., P. F. Lalor, J. A. Eksteen, S. G. Hubscher, M. Briskin, and D. H. Adams. 2005. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J. Immunol. 174:1055-1062.
15. Hiscott, J. 2007. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18:483-490.
16. Kadoya, H., M. Nagano-Fujii, L. Deng, N. Nakazono, and H. Hotta. 2005. Nonstructural proteins 4A and 4B of hepatitis C virus transactivate the interleukin 8 promoter. Microbiol. Immunol. 49:265-273.
17. Konan, K. V., T. H. Giddings, Jr., M. Ikeda, K. Li, S. M. Lemon, and K. Kirkegaard. 2003. Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus. J. Virol. 77:7843-7855.
18. Kusano, F., Y. Tanaka, F. Marumo, and C. Sato. 2000. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab. Investig. 80:415-422.
19. Leroy, V., I. Vigan, J. F. Mosnier, T. Dufeu-Duchesne, M. Pernollet, J. P. Zarski, P. N. Marche, and E. Jouvin-Marche. 2003. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 38:829-841.
20. Li, K., E. Foy, J. C. Ferreon, M. Nakamura, A. C. Ferreon, M. Ikeda, S. C. Ray, M. Gale, Jr., and S. M. Lemon. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102:2992-2997.
21. Li, K., T. Prow, S. M. Lemon, and M. R. Beard. 2002. Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells. Hepatology 35:1237-1246.
22. Lin, R., P. Genin, Y. Mamane, and J. Hiscott. 2000. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 20:6342-6353.
23. Lin, R., C. Heylbroeck, P. Genin, P. M. Pitha, and J. Hiscott. 1999. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol. Cell. Biol. 19:959-966.
24. Liu, Y. Q., R. T. Poon, J. Hughes, Q. Y. Li, W. C. Yu, and S. T. Fan. 2005. Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma. World J. Gastroenterol. 11:164-170.
25. Majumder, S., L. Z. Zhou, P. Chaturvedi, G. Babcock, S. Aras, and R. M. Ransohoff. 1998. Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines. J. Neurosci. Res. 54:169-180.
26. Medin, C. L., K. A. Fitzgerald, and A. L. Rothman. 2005. Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J. Virol. 79:11053-11061.
27. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172.
28. Napoli, J., G. A. Bishop, P. H. McGuinness, D. M. Painter, and G. W. McCaughan. 1996. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24:759-765.
29. Nelson, D. R., R. P. Gonzalez-Peralta, K. Qian, Y. Xu, C. G. Marousis, G. L. Davis, and J. Y. Lau. 1997. Transforming growth factor-beta 1 in chronic hepatitis C. J. Viral Hepat. 4:29-35.
30. Nelson, D. R., H. L. Lim, C. G. Marousis, J. W. Fang, G. L. Davis, L. Shen, M. S. Urdea, J. A. Kolberg, and J. Y. Lau. 1997. Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig. Dis. Sci. 42:2487-2494.
31. Nischalke, H. D., J. Nattermann, H. P. Fischer, T. Sauerbruch, U. Spengler, and F. L. Dumoulin. 2004. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C. Mediators Inflamm. 13:357-359.
32. Petkovic, V., C. Moghini, S. Paoletti, M. Uguccioni, and B. Gerber. 2004. I-TAC/CXCL11 is a natural antagonist for CCR5. J. Leukoc. Biol. 76:701-708.
33. Pichlmair, A., and C. Reis e Sousa. 2007. Innate recognition of viruses. Immunity 27:370-383.
34. Robbiani, D. F., R. A. Finch, D. Jager, W. A. Muller, A. C. Sartorelli, and G. J. Randolph. 2000. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103:757-768.
35. Roe, B., S. Coughlan, J. Hassan, A. Grogan, G. Farrell, S. Norris, C. Bergin, and W. W. Hall. 2007. Elevated serum levels of interferon-gamma- inducible protein-10 in patients coinfected with hepatitis C virus and HIV. J. Infect. Dis. 196:1053-1057.
36. Ruggieri, A., M. Franco, I. Gatto, A. Kumar, and M. Rapicetta. 2007. Modulation of RANTES expression by HCV core protein in liver derived cell lines. BMC Gastroenterol. 7:21.
37. Scheuer, P. J. 1991. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 13:372-374.
38. Seeff, L. B. 2002. Natural history of chronic hepatitis C. Hepatology 36:S35-S46.
39. Shields, P. L., C. M. Morland, M. Salmon, S. Qin, S. G. Hubscher, and D. H. Adams. 1999. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J. Immunol. 163:6236-6243.
40. Soo, H. M., A. Garzino-Demo, W. Hong, Y. H. Tan, Y. J. Tan, P. Y. Goh, S. G. Lim, and S. P. Lim. 2002. Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES. Virology 303:253-277.
41. Sumpter, R., Jr., Y. M. Loo, E. Foy, K. Li, M. Yoneyama, T. Fujita, S. M. Lemon, and M. Gale, Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-2699.
42. Tensen, C. P., J. Flier, S. S. Rampersad, S. Sampat-Sardjoepersad, R. J. Scheper, D. M. Boorsma, and R. Willemze. 1999. Genomic organization, sequence and transcriptional regulation of the human CXCL 11(1) gene. Biochim. Biophys. Acta 1446:167-172.
43. Wagoner, J., M. Austin, J. Green, T. Imaizumi, A. Casola, A. Brasier, K. S. Khabar, T. Wakita, M. Gale, Jr., and S. J. Polyak. 2007. Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J. Virol. 81:309-318.
44. Wuyts, A., N. Van Osselaer, A. Haelens, I. Samson, P. Herdewijn, A. Ben-Baruch, J. J. Oppenheim, P. Proost, and J. Van Damme. 1997. Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry 36:2716-2723.
45. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.
46. Yoshida, T., T. Imai, S. Takagi, M. Nishimura, I. Ishikawa, T. Yaoi, and O. Yoshie. 1996. Structure and expression of two highly related genes encoding SCM-1/human lymphotactin. FEBS Lett. 395:82-88.
47. Zeremski, M., L. M. Petrovic, and A. H. Talal. 2007. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J. Viral Hepat. 14:675-687.
48. Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102:9294-9299.